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Drug utilization research (DUR) is defined as "the marketing, distribution, prescription, and use of drugs in a society, with special emphasis on resulting medical, social and economic consequences." [1] According to WHO estimation, more than 50% of drugs are prescribed, dispensed or sold irrelevantly. [2] In addition, about one-third of the world population do not have access to essential drugs. [2, 3] In low-income countries, irrational use of drugs like overuse of drugs (polypharmacy), use of injectable drugs when not necessary and unnecessary use of antibiotics in non-bacterial infections are common problems. [3, 4] This could lead to interactions in between drugs, adverse outcome of treatment, increased burden of treatment cost leading to mortality of patients. [4] Hence, drug utilization studies are usually conducted in healthcare providing settings to analyze prescribing trend of medicines and to detect whether drugs prescribing patterns are rational or irrational. [4] Generally, in Orthopedics and Obstetrics / Gynecology (OBGYN) departments, studies are mainly conducted on surgical procedures because of topic of interest. Only limited studies are available on DUR and rational use of drugs worldwide. Similarly, some studies have been published in Nepal in various departments of tertiary care hospital. However, there is insufficiency of literatures. Therefore, this study aims to provide understanding of drug utilization pattern by using WHO Core Prescribing Indicator in Orthopedics and OBGYN departments of tertiary care hospital.
METHODS:
A The exclusion criteria were:
• Follow up patient encountered previously on first visit
• Patient prescribed no drug in OPD prescription form
• Patient prescribed herbal medicines in OPD prescription form Information were retrieved from OPD prescription forms and collected in pre-designed study proforma. The proforma included demographic profile and specific information necessary for measuring WHO Core Prescribing Indicator. All the information gathered was kept confidential.
Sample size calculation:
• Sample size calculated by using following formula: [4] n = z2 p (1-p) / d2 Where; p = estimate of proportion with inappropriate prescription pattern, 0.5 as there was no research finding related to estimate of inappropriate drug utilizing pattern in LMC n = sample size d = margin of sampling error tolerated, 0.05 z = standard normal value of confidence interval of 95%, that was equal to 1.96
After applying formula, the sample size calculated was 384.
The WHO Core Prescribing Indicator was used for DUR and calculated as described below: [1, 4] 1. Average number of drugs prescribed per encounter to estimate the degree of polypharmacy. It was calculated by dividing the total number of drugs prescribed by the number of encounters done. 2. Percentage of drugs prescribed by generic name was calculated to estimate the trend of drug prescription by generic name. It was calculated by dividing the number of drugs prescribed by generic name by total number of drugs prescribed, multiplied by 100. 3. Percentage of encounters in which antibiotic was prescribed. It was calculated by dividing the number of encounters in which an antibiotic prescribed by total number of encounters done, multiplied by 100. 4. Percentage of encounters with an injection prescribed. It was calculated by dividing the number of encounters in which an injection prescribed by total number of encounters done, multiplied by 100. 5. Percentage of drugs prescribed from an essential drug list to estimate the degree to which practices conform to a National Medicine Policy as indicated in the National List of Essential Medicines Nepal (Fifth revision) 2016. [16] It was calculated by dividing number of drugs prescribed which were in essential drug list by total number of drug prescribed, multiplied by 100. All data were entered and coded in EpiData, and then analyzed in Statistical Package for the Social Science (SPSS), version 16. Data were presented as frequency, percentage, mean, and standard deviation (SD). Mean values of continuous variables were compared with independent t-test. Categorical variables were compared with Chi-square test or Fisher-exact test whichever was applicable. P value less than 0.05 was considered as statistically significant.
RESULT:
A total of 444 data of patients were enrolled during the study period. Equal numbers of records were taken from Orthopedics (n = 222) and OBGYN (n = 222) OPDs. 81.1% were female and 18.9% were male ( Table 1 ). Mean ages of female and male were 37.4 years (SD = 14.7) and 42.6 years (SD = 19.8) respectively. The ages of male were significantly higher than female (t [N = 444, df = 105.3] = 2.26, p = 0.02). Fracture was the most common diagnosis in Orthopedics department (16.2%, n = 222) followed by soft tissue injury (15.3%). Likewise, pregnancy was the most common condition in OBGYN department (34.6%) followed by pelvic inflammatory disease (10.8%). Total number of drugs prescribed in both departments was 1163. Calcium was commonly prescribed (11.5%, n = 1163) in both departments followed by pantoprazole (9.8%, n = 1163). Aceclofenac was commonly prescribed in Orthopedics whereas calcium in OBGYN.
Average number of drugs prescribed in prescriptions from both departments was 2.6 ( Table 2 ). Means of number of drugs prescribed in Orthopedics and OBGYN departments were 2.9 (SD = 1.1) and 2.3 (SD = 1.1) respectively. The practice of prescribing number of drugs was slightly more in Orthopedics department. However, the difference was statistically significant (t [N = 444, df = 441.40] = 5.47, p < 0.001). Nearly about half of total drugs (n = 1163) were prescribed in generic name in both departments ( Table 2) . Prescription forms with generic name in Orthopedics department were more than OBGYN. This difference was statistically significant (X2 [N = 444, df =1] = 17.72, P = 0.00002); Table 3 . But, there was an increased tendency to prescribe drugs from essential drug list in OBGYN department compared to Orthopedics. This difference was also statistically significant (X2[N = 444, df =1] = 35.11, p < 0.001); Table 3 . In addition, parenteral drugs were not prescribed very commonly both in Orthopedics and OBGYN OPDs. However, the tendency of prescribing parenteral drugs was slightly more in OBGYN OPDs and the difference was statistically significant (X2 [N = 444, df = 1] = 10.33, p = 0.001); Table 3 .
DISCUSSION:
In this study, we aimed to assess drug utilization pattern by using WHO core prescribing indicators. We found that average numbers of drug prescribed was marginally above WHO ideal value (2.0). Few studies supported our finding and showed that there was practice of polypharmacy. [4, 5] Polypharmacy generally means concurrent use of more than one drug for a given patient. Since this study was conducted at speciality department, so this finding could be justifiable. According to WHO, average of 44% of drugs are prescribed in generic name in Nepal. [1] In our study also near about half of total drugs were prescribed in generic name. Prescription of drugs by generic name is beneficial for rationalization and to decrease cost of drug therapy. Besides this, generic prescriptions are clear to understand and reduce the risk of error during dispensing. In some studies it was found that there was zero prescription of drugs by generic name. [6, 7, 8] However, in few studies about two-third to half of total drugs were prescribed by generic name. [9, 10] . Since many pharmaceutical companies develop and manufacture better drugs in terms of efficacy and safety, so that they promote the practice of prescribing drugs by brand name among the doctors in order to return the cost of manufacturing of drugs. This may be the key factor for decreasing practice of generic prescription. Although generic prescription is always cheaper and more effective, this doesn't hold true for each and every drug.
Inappropriate prescription of antibiotic can potentially lead to antibiotics resistance. Antibiotic resistance increases necessity to require more costly antibiotics to manage common as well as serious type of infections which ultimately increases morbidity, mortality and burden of treatment. In our study, prescriptions with antibiotics were below WHO ideal value. In contrast, some studies showed that antibiotics were prescribed in about half to twothird of total prescriptions form. [11, 12] Antibiotics must be used in case of bacterial infections and must be reserved for the future otherwise we may lose the most powerful tool to treat severe infections in future. Regarding essential drugs, they satisfy the priority healthcare needs of the patients. General population should have access to essential drugs at all time in adequate amount at affordable price. In present study, approximately one-third of patients prescribed drugs from essential drug list. According to WHO, 100% of drugs should be prescribed from essential drug list. [1] Contrary, we have found that more than 90% of drugs were prescribed from essential drug list. [12] While, in support to our study, about onethird to half of total drugs were prescribed from essential drugs list. [13, 14, 15] . Prescribing drugs from essential list is a rational practice. The practice of prescription of drugs from essential drug list is not sufficient to meet WHO criteria in our tertiary level hospital. However, this finding is justifiable because in tertiary level hospitals variety of cases are treated and only limited drugs are available in essential drug list. So it is not always necessary to prescribe drugs only from that list.
The limitation of study is that WHO core prescribing indicator highlighted only major problem while prescribing drugs. But, it did not show the reason of existing problem. Besides this, small sample size study was conducted for short duration in only one hospital which may not reflect the actual scenario of the country. However, we expect that this study may create a small basis for carrying study in larger sample and for longer duration in future.
CONCLUSION:
The study concluded that the average number of drugs prescribed in this study was slightly over WHO standards. However, the tendency to prescribe drugs in generic name and from essential drug list didn't meet the ideal values of WHO drug prescribing indicator. So this study emphasizes more on prescribing more drugs in generic name and from essential drug list to meet standards of WHO.
